Three million doses of Chinese Covid-19 Sinopharm vaccines arrive in Tripoli

Al-Sayeh said over half a million people were vaccinated last August

The Head of the National Center for Disease Control (NCDC/CDC) Hayder Al-Sayeh said three million doses of the Chinese vaccine of Coronavirus, Sinopharm, arrived in Libya, warning of a fourth wave of Coronavirus in the beginning of 2022.

Al-Sayeh said in a press conference that the number of vaccine doses that arrived in Libya had reached 7.289.000, adding that the Sinopharm doses reached 5 million with an expiration period of two upcoming years.

He also said that 30% of the total number of vaccine doses had been used: 2 million for the first and second jabs, adding that 58% of the patients’ test samples lately were Delta variant positive, which explained the speedy spread of the Coronavirus.

Al-Sayeh said over half a million people were vaccinated last August, 400.000 in last September and in October, 20.000 people are getting vaccinated every day across Libya and in all institutions and facilities, including in prisons. He added that the CDC aims to vaccinate 70% of the people.

On Monday, the CDC registered 238 positive Coronavirus infections, bringing active cases to a total of 64773. It also said that there 21 new deaths, bringing the total number to 4904 deaths since the start of the pandemic in Libya in the summer of 2020.

The views expressed in Op-Ed pieces are those of the author and do not purport to reflect the opinions or views of Libyan Express.
How to submit an Op-Ed: Libyan Express accepts opinion articles on a wide range of topics. Submissions may be sent to oped@libyanexpress.com. Please include ‘Op-Ed’ in the subject line.
You might also like

Submit a Correction

For: Three million doses of Chinese Covid-19 Sinopharm vaccines arrive in Tripoli

Your suggestion have been successfully submitted

There was an error while trying to send your request. Please try again.

Libyan Express will use the information you provide on this form to be in touch with you and to provide updates and marketing.